Artificial Intelligence-Assisted Screening for Patients With Diabetic Retinopathy and Age-Related Macular Degeneration in Family Medicine and Geriatric and Gerontology Care: Protocol for a Pragmatic Randomized Clinical Trial.
BACKGROUND: Diabetic retinopathy (DR) and age-related macular degeneration (AMD) are 2 of the leading causes of vision loss worldwide. Cost-effectiveness analyses will be performed using data derived from the trial results.
BACKGROUND: Diabetic retinopathy (DR) and age-related macular degeneration (AMD) are 2 of the leading causes of vision loss worldwide. Cost-effectiveness analyses will be performed using data derived from the trial results.
What the study was
- Study design
- Randomized controlled trial
- Category
- Public Health
- Maturity
- Potentially Practice-Changing
- Journal
- JMIR research protocols
Why it surfaced
Relevant Aging, longevity, and population health study (near-term clinical implementability) meets standard-priority threshold.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.